Investigation of endometriosis-symptoms and tumor marker CA 125 in women with Von Willebrand disease
Recruiting
- Conditions
- D68.00
- Registration Number
- DRKS00024676
- Lead Sponsor
- Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 104
Inclusion Criteria
female patients at least 18 years who have not reached menopause
-confirmed von Willebrand disease (every type, every severity)
-signed consent
Exclusion Criteria
-male patients
-female patients < 18 years or post-menopausal
-Von Willebrand disease not confirmed
-no signed consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Single blood sampling (5 ml): determination of tumor-marker CA 125 in serum (normally <35 U/ml)
- Secondary Outcome Measures
Name Time Method Survey of different gynecological parameters by patient questionnaire: <br>menstrual-complaints (first menstruation, duration, regularity, bleeding-duration/-intensity, pain), dysmenorrhea, menorrhagia, endometriosis, cervical-cancer, ovarian-cancer in first-degree-relatives, suspected endometriosis or diagnosed endometriosis, other gynecological surgeries, pregnancies (number and outcome: births, miscarriages, abortions, current pregnancy?), contraception (hormone medication?, impact on pain?), other diseases. <br><br>Additional documentation of the following data: Age, known cancer, current infections, ISTH BAT-Score (Rodeghiero et al., 2010), vWD-Type, current vWF-parameters, current treatment of vWD